HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Chen Selected Research

10- N- methylcarbamoyl- 3,7- dimethylamino- 10H- phenothiazine

1/2006Effects of bee venom peptidergic components on rat pain-related behaviors and inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Chen Research Topics

Disease

212Neoplasms (Cancer)
06/2022 - 01/2000
60Infections
03/2021 - 03/2000
45Neoplasm Metastasis (Metastasis)
06/2022 - 08/2000
42Stroke (Strokes)
08/2021 - 09/2000
39Inflammation (Inflammations)
01/2022 - 01/2000
34Breast Neoplasms (Breast Cancer)
05/2022 - 05/2000
30Hepatocellular Carcinoma (Hepatoma)
06/2019 - 01/2000
27Myocardial Infarction
08/2020 - 04/2000
24Necrosis
04/2022 - 08/2000
24Stomach Neoplasms (Stomach Cancer)
02/2021 - 06/2000
23Hypoxia (Hypoxemia)
12/2021 - 01/2000
23Lung Neoplasms (Lung Cancer)
07/2019 - 02/2000
22Thrombosis (Thrombus)
08/2021 - 07/2000
21Ischemia
10/2020 - 04/2000
21Carcinogenesis
05/2019 - 02/2000
21Carcinoma (Carcinomatosis)
01/2019 - 01/2000
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2000
20Pain (Aches)
01/2017 - 01/2000
19Prostatic Neoplasms (Prostate Cancer)
05/2019 - 03/2001
17Hemorrhage
07/2022 - 02/2000
17Wounds and Injuries (Trauma)
09/2021 - 11/2000
17Type 2 Diabetes Mellitus (MODY)
12/2016 - 02/2000
16Hypertension (High Blood Pressure)
01/2022 - 11/2001
15Leukemia
11/2018 - 04/2001
14Burns
04/2022 - 01/2000
14Fibrosis (Cirrhosis)
01/2021 - 01/2000
14Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2014 - 03/2000
12Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 10/2000
12Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 08/2000
11Squamous Cell Carcinoma of Head and Neck
05/2022 - 09/2001
11Melanoma (Melanoma, Malignant)
01/2021 - 10/2000
11Insulin Resistance
05/2019 - 11/2002
11Infarction (Infarctions)
02/2016 - 02/2000
10Body Weight (Weight, Body)
08/2021 - 02/2001
10Obesity
01/2019 - 06/2001
10Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 01/2001
10Colonic Neoplasms (Colon Cancer)
04/2014 - 09/2000
9Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 04/2000
9Sepsis (Septicemia)
12/2021 - 08/2000
9Heart Failure
11/2021 - 02/2000
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2021 - 10/2001
9COVID-19
02/2021 - 01/2020
9Asthma (Bronchial Asthma)
07/2020 - 01/2001
9Lymphatic Metastasis
08/2019 - 02/2000
9Chronic Obstructive Pulmonary Disease (COPD)
02/2019 - 02/2001
9Seizures (Absence Seizure)
01/2017 - 01/2000
8Tuberculosis (Tuberculoses)
02/2022 - 12/2000
8Brain Ischemia (Cerebral Ischemia)
01/2022 - 06/2000
8Death (Near-Death Experience)
09/2021 - 05/2015
8Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2021 - 01/2000

Drug/Important Bio-Agent (IBA)

105Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2000
48Messenger RNA (mRNA)IBA
06/2019 - 01/2000
37Pharmaceutical PreparationsIBA
10/2020 - 01/2000
35DNA (Deoxyribonucleic Acid)IBA
05/2017 - 01/2000
33Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2001
28CytokinesIBA
04/2021 - 03/2001
25Biological ProductsIBA
01/2022 - 01/2000
23EnzymesIBA
12/2020 - 03/2000
18Peptides (Polypeptides)IBA
09/2021 - 10/2000
18MicroRNAs (MicroRNA)IBA
06/2021 - 03/2009
18VaccinesIBA
04/2021 - 10/2005
16Cisplatin (Platino)FDA LinkGeneric
05/2022 - 09/2000
16CollagenIBA
07/2017 - 01/2000
15Transcription Factors (Transcription Factor)IBA
01/2022 - 10/2000
15Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 11/2000
15AntigensIBA
10/2019 - 03/2000
14Phosphotransferases (Kinase)IBA
01/2020 - 12/2000
14salicylhydroxamic acid (SHAM)IBA
04/2019 - 03/2000
13Interleukin-6 (Interleukin 6)IBA
05/2022 - 01/2007
13Glucose (Dextrose)FDA LinkGeneric
12/2021 - 06/2000
13Insulin (Novolin)FDA Link
05/2019 - 12/2001
13Bee Venoms (Bee Venom)IBA
01/2014 - 01/2000
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2019 - 02/2000
12AntibodiesIBA
01/2019 - 01/2000
12AcidsIBA
04/2018 - 01/2000
11LigandsIBA
01/2022 - 12/2001
11CreatinineIBA
09/2021 - 08/2001
11Small Interfering RNA (siRNA)IBA
11/2017 - 01/2010
10Long Noncoding RNAIBA
12/2021 - 01/2016
9RNA (Ribonucleic Acid)IBA
12/2021 - 08/2000
9Caspase 3 (Caspase-3)IBA
04/2021 - 03/2000
9Indicators and Reagents (Reagents)IBA
06/2018 - 01/2001
8Oxygen (Dioxygen)IBA
12/2021 - 06/2002
8BilirubinIBA
09/2021 - 08/2000
8CholesterolIBA
09/2021 - 12/2001
8LipopolysaccharidesIBA
07/2021 - 08/2005

Therapy/Procedure

96Therapeutics
01/2022 - 01/2000
32Drug Therapy (Chemotherapy)
01/2022 - 01/2000
30Transplantation
10/2020 - 01/2000
23Radiotherapy
06/2022 - 12/2001
22Stents
10/2021 - 01/2000
15Percutaneous Coronary Intervention
08/2020 - 09/2013
12Hematopoietic Stem Cell Transplantation
03/2020 - 06/2009
11Immunotherapy
01/2021 - 04/2001
10Aftercare (After-Treatment)
09/2021 - 02/2000
9Ligation
12/2021 - 08/2000
9Kidney Transplantation
09/2021 - 06/2005
9Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2018 - 07/2003
8Length of Stay
05/2022 - 11/2000
8Punctures
12/2021 - 08/2000